Common issues include cross-reactivity, where the antibody binds to similar but unintended antigens, and batch-to-batch variability, especially with polyclonal antibodies. Non-specific binding can occur due to interactions with Fc receptors or non-target components in the tissue, leading to background staining. These issues necessitate rigorous validation and controls.
